Melissa Layman, Chief Commercial Officer at Flexion Therapeutics Inc (FLXN), sold 4,520 shares at $11.80 ($53K) on 2021-03-15, disclosed to the SEC on 2021-03-16.
Open-market sale of $53k FLXN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.